FREE Account Opening + No Clearing Fees
March 17, 2022 - March 22, 2022

achyut-healthcare-ipo Review & Recommendations

Dilip Davda recommend to "Avoid" the IPO.

achyut-healthcare-ipo Review Summary from brokers and analysts

Review By Apply May Apply Neutral Avoid Not Rated
Count 0 0 0 1 0
% 0.00 0.00 0.00 100.00 0.00

achyut-healthcare-ipo Analysis By Brokers/Analysts

Reviewer Recommendation Past Reviews
Dilip Davda Avoid

achyut-healthcare-ipo Review by Dilip Davda (Avoid)

[Dilip Davda]  The company has posted minuscule financial performances till FY21 and has marked bumper top and bottom line for the first half of the current fiscal. Since the company is having third party trading activity, sustainability of such performance going forward is a major concern. Even with this super current earning, its asking price is at a P/E of 54 making it a costly bet. There is no harm in ignoring this pricy offer. Read detail review...

achyut-healthcare-ipo Review by Members

achyut-healthcare-ipo Reviews, analysis and views by popular members. Read Achyut Healthcare Limited IPO reviews by retail investors to find recommended ipo to buy.

Post Recommendation Manage Your IPO Reviews

achyut-healthcare-ipo Review Summary by Members

Review By Apply May Apply Neutral Avoid
Clear Search
Member Review
No recommendation found. Be the first to post the recommendation.

Post Recommendation Manage Recommendations


  • The recommendations or analysis of public issues posted above expresses the views of its author and does not represent the views of or its staff.
  • We reserve the right to remove any objectionable post without providing a reason.